Acuta Capital Partners, LLC Larimar Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

  • $98.8 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$14.61 - $22.19 $12.6 Million - $19.2 Million
-863,100 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$14.28 - $25.06 $472,668 - $829,486
33,100 Added 3.99%
863,100 $18.5 Million
Q3 2020

Nov 16, 2020
BUY
$10.5 - $17.6 $71,725 - $120,225
6,831 Added 0.83%
830,000 $12.6 Million
Q2 2020

Aug 14, 2020
BUY
$0.72 - $16.76 $592,681 - $13.8 Million
823,169 New
823,169 $10.3 Million

Others Institutions Holding LRMR

# of Institutions
128
Shares Held
67.3M
Call Options Held
280K
Put Options Held
76.3K
View Full List

About Larimar Therapeutics, Inc.

LRMR Quotes by TradingView
  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $256M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Acuta Capital Partners, LLC Portfolio

Follow Acuta Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acuta Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email